Cargando…
Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study
BACKGROUND: Tyrosine kinase inhibitors (TKIs) and checkpoint inhibitors have been established as effective treatment for metastatic renal cell carcinoma (mRCC), but only a minority of patients achieve complete response. Additional strategies are necessary to improve these agents’ efficacy. METHODS:...
Autores principales: | Dengina, Natalia, Mitin, Timur, Gamayunov, Sergey, Safina, Sufia, Kreinina, Yuliya, Tsimafeyeu, Ilya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802957/ https://www.ncbi.nlm.nih.gov/pubmed/31673426 http://dx.doi.org/10.1136/esmoopen-2019-000535 |
Ejemplares similares
-
Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies
por: Tsimafeyeu, Ilya, et al.
Publicado: (2021) -
Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022) -
Correction to: Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022) -
Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015) -
Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine
por: Kim, Eunji, et al.
Publicado: (2023)